The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 329.50
Bid: 328.00
Ask: 329.50
Change: 3.00 (0.92%)
Spread: 1.50 (0.457%)
Open: 328.00
High: 330.00
Low: 325.00
Prev. Close: 326.50
PIN Live PriceLast checked at -
Pantheon International is an Investment Trust

To maximise capital growth by investing in a diversified portfolio of private equity funds and occasionally directly in private companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Consolidation and TVR

1 Nov 2017 09:00

RNS Number : 2319V
Pantheon International PLC
01 November 2017
 

FOR IMMEDIATE RELEASE

No securities of the Company referred to in this announcement have been or will be registered under the United States Securities Act of 1933 or the state securities laws of the United States and none of them are being, nor may they be, offered or sold in the United States.

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

PANTHEON INTERNATIONAL PLC

 

1 November 2017

Completion of the Consolidation

and

Total Voting Rights

 

 

 

Pantheon International Plc ("PIP" or the "Company"), an investment trust that invests in private equity funds globally, announces that it has now implemented the Proposals (which include the reorganisation of its share capital), details of which are set out in the circular to shareholders published by the Company on 6 October 2017 (the "Circular").

 

The Proposals consisted of:

 

(a) the redemption by the Company of 9,055,100 Redeemable Shares of 1p each in the capital of the Company ("Redeemable Shares") owned by the largest holder of the Redeemable Shares (the "Investor") for an aggregate consideration of £200 million and the subsequent application of these redemption proceeds for the subscription for the ALN by the Investor;

(b) a bonus issue of new deferred shares of 66p each in the capital of the Company ("Deferred Shares"); and

(c) the subsequent consolidation, sub-division and redesignation of the remaining Redeemable Shares and the Deferred Shares into new ordinary shares of 67p each in the capital of the Company ("New Ordinary Shares"), ranking pari passu in all respects with the existing Ordinary Shares.

 

Total Voting Rights

 

Following Admission of the New Ordinary Shares to the Official List of the UK Listing Authority and to trading on the Main Market for listed securities of the London Stock Exchange, the Company now has 54,304,447 Ordinary Shares of 67p each in the capital of the Company in issue with each Ordinary Share carrying the right to one vote. No shares are held in treasury. Accordingly, the total number of voting rights in the Company is 54,304,447.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Capitalised terms shall have the meaning attributed to them in the Circular unless otherwise defined in this announcement.

 

 

LEI: 2138001B3CE5S5PEE928

 

 

Enquiries:

 

Capita Asset Services (Company Secretary)

James Poole

01392 477500 / 07736 492773

 

Pantheon Ventures (UK) LLP (Manager)

Andrew Lebus / Vicki Bradley

020 3356 1800

 

Evercore

Matthew Lindsey-Clark

020 7653 6000

 

Canaccord Genuity Limited

Andrew Zychowski / Lucy Lewis / Robbie Robertson

020 7523 8000

 

NOTESPIPPIP is a London quoted investment trust, managed by Pantheon Ventures (UK) LLP ("Pantheon"), a leading global private equity fund investor, investing in both primary funds and secondary transactions, and from time to time capitalising further on its fund investment activities by acquiring direct holdings in unquoted companies, usually either where a vendor is seeking to sell a combined portfolio of fund interests and direct holdings or where there is a private equity manager, well known to Pantheon, investing on substantially the same terms. With investments in private equity funds, covering multiple private equity strategies ranging from investments in late stage buyouts to early stage venture, PIP enables individuals as well as institutions to gain access to a substantial portfolio of unquoted companies in the USA, the UK, Continental Europe and Asia, within funds managed by experienced private equity managers.

Pantheon Pantheon is a leading global private equity fund investor that invests on behalf of over 400 institutional investors. Established over 35 years ago, Pantheon has developed a strong reputation and track record in primary, secondary and co-investments and across all stages and geographies. Pantheon has £29.2 billion in AUM** (as at 31 March 2017) 223 employees, including 71 investment professionals, located across offices in London, San Francisco, New York, Hong Kong, Seoul and Bogotá.

** This figure includes assets subject to discretionary or non-discretionary management, advice or those limited to a reporting function.

Evercore

Evercore Partners International LLP ("Evercore"), which is authorised and regulated in the United Kingdom by the FCA, is acting as financial adviser exclusively for the Company and no one else in connection with the proposed transactions described in this announcement and the content of this announcement and accordingly will not be responsible to anyone other than the Company in providing the protections afforded to clients of Evercore nor for providing advice in relation to the proposed transactions described in this announcement and the content of this announcement. Neither Evercore nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person other than the Company in connection with this announcement, any statement contained herein or otherwise.

 

Canaccord

Canaccord Genuity Limited ("Canaccord"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and for no-one else in connection with the proposed transactions described in this announcement and the content of this announcement, and accordingly will not be responsible to anyone other than the Company for providing the protections offered to clients of Canaccord nor for providing advice to any other person in relation to the proposed transactions described in this announcement or the contents of this announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKDDPFBDKODK
Date   Source Headline
2nd May 202412:38 pmRNSDirector/PDMR Shareholding
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20249:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:01 amRNSMonthly Performance Update
26th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20243:52 pmRNSInvestor Presentation
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20245:35 pmRNSHolding(s) in Company
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202412:24 pmRNSHolding(s) in Company
2nd Apr 202412:03 pmRNSTotal Voting Rights
28th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSMonthly Performance Update
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 202412:43 pmRNSHolding(s) in Company
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 202410:55 amRNSTotal Voting Rights
29th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:01 amRNSMonthly Performance Update
27th Feb 20247:00 amRNSTransaction in Own Shares
26th Feb 20242:42 pmRNSHolding(s) in Company
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:02 amRNSHalf-year Report
22nd Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 202412:59 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.